Intermountain Builds Up Bioinformatics to Make HerediGene Sequencing Data Clinically Actionable
The health system, which has now enrolled 150,000 people in its population genomics program, has implemented its technology across CDC tier one conditions but has grander ambitions.
Myriad Genetics, Clarified Precision Medicine Team up on Molecular Tumor Board Service
The companies have advanced an MTB service that will help oncologists interpret results from Myriad's germline, tumor profiling, and companion tests.
Tempus, Intermountain Healthcare Strike Precision Cancer Research Alliance
Intermountain will use Tempus' next-generation sequencing-based cancer assay to study patient samples to advance research into precision patient care.
Intermountain Healthcare Rolling Out Galleri Multi-Cancer Early Detection Test in Pilot Program
The test is first available to employees over age 50 covered under Intermountain's SelectHealth, but the health system has a bigger five-year plan.
The company is offering combined germline and somatic cancer testing, and sharing patients' variants identified through that testing in a new research registry.